Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age
Public ClinicalTrials.gov record NCT00643916. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Immunogenicity of a Tetravalent (A, C, Y, and W-135) Meningococcal Diphtheria Toxoid Conjugate Vaccine (TetraMenD) In Toddlers 9 to 18 Months of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical trial is to describe the safety and immunogenicity of one or two doses of Menactra® (TetraMenD) administered in children less than 2 years of age. Primary Objective: To describe the immunogenicity profile of one or two doses of Menactra® (TetraMenD) when administered to subjects aged 9, 12, 15, or 18 months in comparison to the immunogenicity of one dose of Menomune® when administered to children aged 3 years to \<6 years of age.
Study identification
- NCT ID
- NCT00643916
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 378 participants
Conditions and interventions
Conditions
Interventions
- Meningococcal Polysaccharide Diphtheria Protein Conjugate (Menactra®) Biological
- A/C/Y/W-135, Meningococcal Polysaccharide Vaccine (Menomune®) Biological
Biological
Eligibility (public fields only)
- Age range
- 9 Months to 5 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2004
- Primary completion
- Feb 28, 2006
- Completion
- Sep 30, 2007
- Last update posted
- Feb 13, 2014
2004 – 2007
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Norwich | Connecticut | 06360 | — |
| Not listed | Atlanta | Georgia | 30322 | — |
| Not listed | Marietta | Georgia | 30062 | — |
| Not listed | Bardstown | Kentucky | 40004 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Woburn | Massachusetts | 01801 | — |
| Not listed | Akron | Ohio | 44308 | — |
| Not listed | Columbus | Ohio | 43205 | — |
| Not listed | Drexel Hill | Pennsylvania | 19026 | — |
| Not listed | Pittsburgh | Pennsylvania | 15241 | — |
| Not listed | Sellersville | Pennsylvania | 18960 | — |
| Not listed | Kingsport | Tennessee | 37664 | — |
| Not listed | Salt Lake City | Utah | 84123 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00643916, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 13, 2014 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00643916 live on ClinicalTrials.gov.